{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T12:59:31Z","timestamp":1794315571894,"version":"4.9.0"},"reference-count":166,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2025206897"],"award-info":[{"award-number":["H2025206897"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2024206222"],"award-info":[{"award-number":["H2024206222"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012505","name":"Hebei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012505","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473069"],"award-info":[{"award-number":["82473069"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.neo.2026.101322","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T12:05:52Z","timestamp":1780920352000},"page":"101322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A malignant symbiosis: The neuro-metabolic symphony rewires the tumor microenvironment"],"prefix":"10.1016","volume":"78","author":[{"given":"Zhendong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianxu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-4624","authenticated-orcid":false,"given":"Lihua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neo.2026.101322_bib0001","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment: from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0002","article-title":"Tumor microenvironment in glioblastoma: current and emerging concepts","volume":"5","author":"Sharma","year":"2023","journal-title":"Neurooncol. Adv."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0003","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13046-023-02634-z","article-title":"Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment","volume":"42","author":"Tan","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.neo.2026.101322_bib0004","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.7150\/thno.82920","article-title":"The role of lipid metabolic reprogramming in tumor microenvironment","volume":"13","author":"Yang","year":"2023","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0005","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0006","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-024-01600-2","article-title":"Cancer associated fibroblasts and metabolic reprogramming: unraveling the intricate crosstalk in tumor evolution","volume":"17","author":"Zhang","year":"2024","journal-title":"J. Hematol. Oncol."},{"issue":"3","key":"10.1016\/j.neo.2026.101322_bib0007","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","article-title":"Cancer hallmarks intersect with neuroscience in the tumor microenvironment","volume":"41","author":"Hanahan","year":"2023","journal-title":"Cancer Cell"},{"issue":"10","key":"10.1016\/j.neo.2026.101322_bib0008","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/s41573-024-01017-z","article-title":"Targeting the peripheral neural-tumour microenvironment for cancer therapy","volume":"23","author":"Yaniv","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neo.2026.101322_bib0009","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41586-023-05968-y","article-title":"The neuroscience of cancer","volume":"618","author":"Mancusi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.neo.2026.101322_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2026.102015","article-title":"Neurotransmitters: key regulators of the tumor immune microenvironment","volume":"81","author":"Zhang","year":"2026","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.neo.2026.101322_bib0011","article-title":"The neuro-immune axis in cancer: mechanisms of innervation-driven tumor progression and therapeutic opportunities","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.neo.2026.101322_bib0012","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70708","article-title":"Cancer Neuroscience: innovative conception and emerging strategy of therapy","volume":"7","author":"Wang","year":"2026","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0013","first-page":"73","article-title":"Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies","volume":"12","author":"Liu","year":"2025","journal-title":"Mil. Med. Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0014","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1186\/s12967-025-06657-2","article-title":"Sympathetic nervous system in tumor progression and metabolic regulation: mechanisms and clinical potential","volume":"23","author":"Sun","year":"2025","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.neo.2026.101322_bib0015","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/pros.24455","article-title":"Inhibition of signaling downstream of beta-2 adrenoceptor by propranolol in prostate cancer cells","volume":"83","author":"Alaskar","year":"2023","journal-title":"Prostate"},{"issue":"7","key":"10.1016\/j.neo.2026.101322_bib0016","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.7150\/ijbs.79583","article-title":"Chronic stress promotes colorectal cancer progression by enhancing glycolysis through \u03b22-AR\/CREB1 signal pathway","volume":"19","author":"Guan","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neo.2026.101322_bib0017","article-title":"Norepinephrine enhances aerobic glycolysis and may act as a predictive factor for immunotherapy in gastric cancer","volume":"2021","author":"Wang","year":"2021","journal-title":"J. Immunol. Res."},{"issue":"5","key":"10.1016\/j.neo.2026.101322_bib0018","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1111\/jvim.17148","article-title":"Metabolomic profiling of pheochromocytomas in dogs: catecholamine phenotype and tricarboxylic acid cycle metabolites","volume":"38","author":"van den Berg","year":"2024","journal-title":"J. Vet. Internal Med."},{"issue":"33","key":"10.1016\/j.neo.2026.101322_bib0019","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ado1533","article-title":"Epinephrine promotes breast cancer metastasis through a ubiquitin-specific peptidase 22-mediated lipolysis circuit","volume":"10","author":"Zhou","year":"2024","journal-title":"Sci. Adv."},{"issue":"4","key":"10.1016\/j.neo.2026.101322_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109883","article-title":"\u03b22-adrenergic receptor signaling regulates metabolic pathways critical to myeloid-derived suppressor cell function within the TME","volume":"37","author":"Mohammadpour","year":"2021","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.neo.2026.101322_bib0021","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.3390\/ijms23031325","article-title":"Blockade of \u03b22-adrenergic receptor reduces inflammation and oxidative stress in clear cell renal cell carcinoma","volume":"23","author":"Albi\u00f1ana","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2026.101322_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.119517","article-title":"Paeoniflorin inhibits chronic restraint stress-induced progression of hepatocellular carcinoma through suppressing norepinephrine-induced activation of hepatic stellate cells via SRC\/AKT\/ERK pathways","volume":"344","author":"Luo","year":"2025","journal-title":"J. Ethnopharmacol."},{"issue":"23","key":"10.1016\/j.neo.2026.101322_bib0023","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1523\/JNEUROSCI.2504-21.2022","article-title":"Ubiquitin-specific protease 2 in the ventromedial hypothalamus modifies blood glucose levels by controlling sympathetic nervous activation","volume":"42","author":"Hashimoto","year":"2022","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neo.2026.101322_bib0024","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jnr.24733","article-title":"Noradrenaline protects neurons against H(2) O(2) -induced death by increasing the supply of glutathione from astrocytes via \u03b2(3) -adrenoceptor stimulation","volume":"99","author":"Yoshioka","year":"2021","journal-title":"J. Neurosci. Res."},{"issue":"3","key":"10.1016\/j.neo.2026.101322_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189103","article-title":"Adipose tissue rearrangement in cancer cachexia: the involvement of \u03b23-adrenergic receptor associated pathways","volume":"1879","author":"Mota","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"11","key":"10.1016\/j.neo.2026.101322_bib0026","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1093\/carcin\/bgae056","article-title":"ADRA2A promotes the classical\/progenitor subtype and reduces disease aggressiveness of pancreatic cancer","volume":"45","author":"Moreno","year":"2024","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.neo.2026.101322_bib0027","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1002\/cbf.3831","article-title":"Upregulation by duloxetine of the transforming growth factor-\u03b1-induced migration of hepatocellular carcinoma cells via enhancement of the c-Jun N-terminal kinase activity","volume":"41","author":"Matsushima-Nishiwaki","year":"2023","journal-title":"Cell Biochem. Funct."},{"issue":"19","key":"10.1016\/j.neo.2026.101322_bib0028","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1002\/cncr.35426","article-title":"Role of epigenetic regulation on catecholamine synthesis in pheochromocytoma and paraganglioma","volume":"130","author":"Kaplinsky","year":"2024","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.neo.2026.101322_bib0029","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1080\/00365513.2021.1980901","article-title":"Study of stability and interference for catecholamines and metanephrines, 3-methoxytyramine: key point of an accurate diagnosis for pheochromocytoma and paraganglioma","volume":"81","author":"Wang","year":"2021","journal-title":"Scand. J. Clin. Lab Invest."},{"key":"10.1016\/j.neo.2026.101322_bib0030","article-title":"Profiling the metabolome of uterine fluid for early detection of ovarian cancer","volume":"4","author":"Wang","year":"2023","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.neo.2026.101322_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2025.115193","article-title":"Polynorepinephrine nanoagent enables targeted mitochondrial delivery for enhanced tumor therapy through ferroptosis","volume":"257","author":"Lyu","year":"2026","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"8","key":"10.1016\/j.neo.2026.101322_bib0032","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/jpp\/rgaf031","article-title":"Ginsenoside Rb1 inhibits chronic stress-induced colorectal cancer via regulating glycolysis and \u03b22-AR\/CREB1 signaling pathway","volume":"77","author":"Yao","year":"2025","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.neo.2026.101322_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116985","article-title":"Quercetin inhibits chronic stress-mediated progression of triple-negative breast cancer by blocking \u03b2(2)-AR\/ERK1\/2 pathway","volume":"177","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.neo.2026.101322_bib0034","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s11655-025-4127-z","article-title":"Sini powder alleviates stress response and suppresses hepatocellular carcinoma development by restoring gut microbiota","volume":"31","author":"Mei","year":"2025","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.neo.2026.101322_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104149","article-title":"Beta-blockers disrupt mitochondrial bioenergetics and increase radiotherapy efficacy independently of beta-adrenergic receptors in medulloblastoma","volume":"82","author":"Rossi","year":"2022","journal-title":"EBioMedicine"},{"issue":"3","key":"10.1016\/j.neo.2026.101322_bib0036","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41388-019-1006-0","article-title":"Neurotransmitters: emerging targets in cancer","volume":"39","author":"Jiang","year":"2020","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.neo.2026.101322_bib0037","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.7150\/ijbs.117013","article-title":"Acetylcholine enhances HIF-1\u03b1 signaling in pancreatic cancer cells under hypoxia through the nAChR-\u03b17\/PDPK1\/YAP pathway","volume":"22","author":"Cho","year":"2026","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.neo.2026.101322_bib0038","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105336","article-title":"Choline and nicotine increase glioblastoma cell proliferation by binding and activating \u03b17- and \u03b19- containing nicotinic receptors","volume":"163","author":"Pucci","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.neo.2026.101322_bib0039","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289098","article-title":"\u03b17 nicotinic acetylcholine receptor interaction with G proteins in breast cancer cell proliferation, motility, and calcium signaling","volume":"18","author":"Oz","year":"2023","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.neo.2026.101322_bib0040","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/s41419-024-07178-4","article-title":"Nicotine-induced CHRNA5 activation modulates CES1 expression, impacting head and neck squamous cell carcinoma recurrence and metastasis via MEK\/ERK pathway","volume":"15","author":"Feng","year":"2024","journal-title":"Cell Death Dis."},{"issue":"6","key":"10.1016\/j.neo.2026.101322_bib0041","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/s12276-023-00994-2","article-title":"The tobacco-specific carcinogen NNK induces pulmonary tumorigenesis via nAChR\/Src\/STAT3-mediated activation of the renin-angiotensin system and IGF-1R signaling","volume":"55","author":"Boo","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.neo.2026.101322_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111579","article-title":"Exposure of human neuroblastoma SH-SY5Y cells to amphetamine-type stimulants leads to oxidative-antioxidative imbalance associated with DNA damage and acetylcholine antagonism","volume":"417","author":"Zandona","year":"2025","journal-title":"Chem. Biol. Interact."},{"issue":"7","key":"10.1016\/j.neo.2026.101322_bib0043","first-page":"1727","article-title":"M2 Muscarinic receptor activation impairs mitotic progression and bipolar mitotic spindle formation in human","volume":"10","author":"Di Bari","year":"2021","journal-title":"Glioblastoma Cell Lines, Cells"},{"issue":"11","key":"10.1016\/j.neo.2026.101322_bib0044","doi-asserted-by":"crossref","first-page":"6754","DOI":"10.1007\/s12035-022-03003-1","article-title":"Antagonism of the muscarinic acetylcholine type 1 receptor enhances mitochondrial membrane potential and expression of Respiratory chain components via AMPK in Human neuroblastoma SH-SY5Y cells and primary neurons","volume":"59","author":"Naznin","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0045","doi-asserted-by":"crossref","first-page":"81","DOI":"10.21873\/anticanres.17395","article-title":"Epigenetic modification of muscarinic acetylcholine receptors in squamous cell carcinoma of the head and neck","volume":"45","author":"Sugiyama","year":"2025","journal-title":"Anticancer Res."},{"issue":"9","key":"10.1016\/j.neo.2026.101322_bib0046","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.1021\/acs.jmedchem.0c01714","article-title":"In vivo receptor visualization and evaluation of receptor occupancy with positron emission tomography","volume":"64","author":"Takamura","year":"2021","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.neo.2026.101322_bib0047","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/s41388-021-01682-z","article-title":"Repurposing dextromethorphan and metformin for treating nicotine-induced cancer by directly targeting CHRNA7 to inhibit JAK2\/STAT3\/SOX2 signaling","volume":"40","author":"Wang","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2026.101322_bib0048","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.121078","article-title":"Neurokinin 3 receptor antagonist-induced adipocyte activation improves obesity and metabolism in PCOS-like mice","volume":"310","author":"Zhang","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.neo.2026.101322_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112546","article-title":"MC1R regulates T regulatory cell differentiation through metabolic reprogramming to promote colon cancer","volume":"138","author":"Zhu","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0050","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1186\/s12885-021-08902-5","article-title":"A lipid metabolism-related genes prognosis biomarker associated with the tumor immune microenvironment in colorectal carcinoma","volume":"21","author":"Yang","year":"2021","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.neo.2026.101322_bib0051","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3390\/genes12020139","article-title":"Role of Sigma-1 receptor in calcium modulation: possible involvement in cancer","volume":"12","author":"Pontisso","year":"2021","journal-title":"Genes"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0052","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/1878-0261.12815","article-title":"Neurotensin receptor 1 signaling promotes pancreatic cancer progression","volume":"15","author":"Takahashi","year":"2021","journal-title":"Mol. Oncol."},{"issue":"23","key":"10.1016\/j.neo.2026.101322_bib0053","doi-asserted-by":"crossref","first-page":"25186","DOI":"10.1021\/acs.jmedchem.5c02195","article-title":"A novel radiotracer for NTSR1-targeted PET imaging of tumor: preclinical and first-in-Human studies","volume":"68","author":"Zhu","year":"2025","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.neo.2026.101322_bib0054","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1021\/acs.molpharmaceut.4c01324","article-title":"Enhanced retention of NTSR1-targeted radionuclide therapeutics via covalent inhibitors in pancreatic, colorectal, and prostate cancer models","volume":"22","author":"Zhang","year":"2025","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41419-021-04485-y","article-title":"Neurokinin-1 receptor promotes non-small cell lung cancer progression through transactivation of EGFR","volume":"13","author":"Zhang","year":"2022","journal-title":"Cell Death Dis."},{"issue":"21","key":"10.1016\/j.neo.2026.101322_bib0056","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110786","article-title":"Butylated neuropeptide antagonist targeting hypoxia-induced GRPR overexpression in small cell lung cancer","volume":"26","author":"Deureh","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"Pt 3","key":"10.1016\/j.neo.2026.101322_bib0057","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.semcancer.2022.03.023","article-title":"Metabolic reservoir cycles in cancer","volume":"86","author":"Zhang","year":"2022","journal-title":"Semin. Cancer Biol."},{"issue":"12","key":"10.1016\/j.neo.2026.101322_bib0058","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2022112675","article-title":"Glutamate dehydrogenase1 supports HIF-1\u03b1 stability to promote colorectal tumorigenesis under hypoxia","volume":"42","author":"Hu","year":"2023","journal-title":"Embo J."},{"issue":"9","key":"10.1016\/j.neo.2026.101322_bib0059","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.31557\/APJCP.2025.26.9.3157","article-title":"Fueling prostate cancer: the Central role of glutamine\/glutamate metabolic reprogramming","volume":"26","author":"Alhallaq","year":"2025","journal-title":"Asian Pac J Cancer Prev"},{"issue":"11","key":"10.1016\/j.neo.2026.101322_bib0060","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.70036","article-title":"Glutaminase-1 mediated glutaminolysis to glutathione synthesis maintains redox homeostasis and modulates ferroptosis sensitivity in cancer cells","volume":"58","author":"Bai","year":"2025","journal-title":"Cell Prolif"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0061","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-64983-x","article-title":"The SLC1A1\/EAAT3 dicarboxylic amino acid transporter is an epigenetically dysregulated nutrient carrier that sustains oncogenic metabolic programs","volume":"16","author":"Grubb","year":"2025","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.neo.2026.101322_bib0062","doi-asserted-by":"crossref","first-page":"388","DOI":"10.3390\/cells14050388","article-title":"HOTAIR participation in glycolysis and glutaminolysis through lactate and glutamate production in colorectal cancer","volume":"14","author":"Flores-Garc\u00eda","year":"2025","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0063","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2025.2497172","article-title":"Glutamate promotes CCL2 expression to recruit tumor-associated macrophages by restraining EZH2-mediated histone methylation in hepatocellular carcinoma","volume":"14","author":"Chen","year":"2025","journal-title":"Oncoimmunology"},{"issue":"11","key":"10.1016\/j.neo.2026.101322_bib0064","doi-asserted-by":"crossref","first-page":"4869","DOI":"10.21873\/anticanres.17312","article-title":"Role of glutamine synthetase on vascular permeability in gliomas","volume":"44","author":"Wang","year":"2024","journal-title":"Anticancer Res."},{"issue":"9","key":"10.1016\/j.neo.2026.101322_bib0065","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1007\/s11064-023-03947-3","article-title":"The regulation of GLT-1 degradation pathway by SIRT4","volume":"48","author":"Ye\u015fil\u00f6ren","year":"2023","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neo.2026.101322_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217907","article-title":"NF-\u03bab-mediated cytokine secretion and glutamate metabolic reprogramming converge in breast cancer brain tropism","volume":"630","author":"Di Russo","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.neo.2026.101322_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140264","article-title":"Glutamate molecular structure and protein affect the inhibition of breast cancer cell metastasis: cell-derived exosomes inhibitory effects through the MAPK signaling pathway","volume":"300","author":"Chen","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0068","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s13046-023-02830-x","article-title":"Cystine\/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models","volume":"42","author":"Ruiu","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.neo.2026.101322_bib0069","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf532","article-title":"An engineered glutamic acid tRNA for efficient suppression of pathogenic nonsense mutations","volume":"53","author":"Specht","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.neo.2026.101322_bib0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114410","article-title":"GABAergic signaling as a potential therapeutic target in cancers","volume":"161","author":"Yang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"12","key":"10.1016\/j.neo.2026.101322_bib0071","doi-asserted-by":"crossref","DOI":"10.1093\/jleuko\/qiaf166","article-title":"Gamma-aminobutyric acid-B receptor axis promotes proliferation and survival of multiple myeloma cells via enhancing ERK1\/2 activity","volume":"117","author":"Hu","year":"2025","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0072","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1186\/s13046-023-02921-9","article-title":"GABA induced by sleep deprivation promotes the proliferation and migration of colon tumors through miR-223-3p endogenous pathway and exosome pathway","volume":"42","author":"Bao","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0073","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s13287-022-03087-5","article-title":"Propofol enhances stem-like properties of glioma via GABA(A)R-dependent Src modulation of ZDHHC5-EZH2 palmitoylation mechanism","volume":"13","author":"Fan","year":"2022","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0074","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13046-025-03315-9","article-title":"GABA regulates metabolic reprogramming to mediate the development of brain metastasis in non-small cell lung cancer","volume":"44","author":"Xie","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.neo.2026.101322_bib0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ceca.2025.103050","article-title":"GAT3-dependent regulation of glioma invasiveness via a lipid raft-associated PMCA4 Ca(2+) transporter and a downstream CaMKII\/CREB signaling - implications for compartmentalized signaling in glioma tumors","volume":"130","author":"Sobolczyk-Prawda","year":"2025","journal-title":"Cell Calcium"},{"key":"10.1016\/j.neo.2026.101322_bib0076","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140679","article-title":"Targeted therapeutic strategy for oral squamous carcinoma using celecoxib-loaded GABA\/wheat gluten-alginate nanocarrier hydrogel with glutathione down-regulation and enhanced CCND2-mediated apoptosis","volume":"303","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"7","key":"10.1016\/j.neo.2026.101322_bib0077","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1750","article-title":"Serotonin signaling in cancer: emerging mechanisms and therapeutic opportunities","volume":"14","author":"Chen","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.neo.2026.101322_bib0078","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117428","article-title":"Inhibition of HTR2B-mediated serotonin signaling in colorectal cancer suppresses tumor growth through ERK signaling","volume":"179","author":"Lee","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neo.2026.101322_bib0079","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2021.112662","article-title":"Effects of bisphenol A on the proliferation, migration, and tumor growth of colon cancer cells: in vitro and in vivo evaluation with mechanistic insights related to ERK and 5-HT3","volume":"158","author":"Jun","year":"2021","journal-title":"Food Chem. Toxicol."},{"issue":"11","key":"10.1016\/j.neo.2026.101322_bib0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0335398","article-title":"Comprehensive bioinformatic analysis of HTR7: a potential biomarker for diagnosis, survival, and immunotherapy in pan-cancer","volume":"20","author":"Yao","year":"2025","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.neo.2026.101322_bib0081","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1021\/acs.molpharmaceut.1c00172","article-title":"Synthesis and biological evaluation of (99m)Tc-labeled phenylpiperazine derivatives as selective serotonin-7 receptor ligands for brain tumor imaging","volume":"18","author":"Saednia","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.neo.2026.101322_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177081","article-title":"The effect of cancer-associated mutations on ligand binding and receptor function - a case for the 5-HT(2C) receptor","volume":"985","author":"Feng","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neo.2026.101322_bib0083","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175230","article-title":"Anticancer efficacy of endo- and exogenous potent ligands acting at dopaminergic receptor-expressing cancer cells","volume":"932","author":"Laskowska","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"20","key":"10.1016\/j.neo.2026.101322_bib0084","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1158\/0008-5472.CAN-21-1043","article-title":"Psychologic stress drives progression of malignant tumors via DRD2\/HIF1\u03b1 signaling","volume":"81","author":"Liu","year":"2021","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.neo.2026.101322_bib0085","doi-asserted-by":"crossref","DOI":"10.3892\/or.2021.8025","article-title":"Dopamine receptor D1 agonist inhibits glioblastoma via calpain\u2011mediated ER stress and mitochondrial dysfunction","volume":"45","author":"Yang","year":"2021","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.neo.2026.101322_bib0086","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/eji.202048957","article-title":"Metabolic and inflammatory reprogramming of macrophages by ONC201 translates in a pro-inflammatory environment even in presence of glioblastoma cells","volume":"51","author":"Gei\u00df","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neo.2026.101322_bib0087","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156707","article-title":"Valproic acid promotes transcriptional activation of Drd2 by mediating histone acetylation to inhibit the mTOR-Pttg1 signaling axis and exerts anti-PitNETs activity","volume":"141","author":"Du","year":"2025","journal-title":"Phytomedicine"},{"issue":"23","key":"10.1016\/j.neo.2026.101322_bib0088","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252312483","article-title":"The activation of p300 enhances the sensitivity of pituitary adenomas to dopamine agonist treatment by regulating the transcription of DRD2","volume":"25","author":"Li","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2026.101322_bib0089","article-title":"A novel mechanism regulating dopamine receptor type 2 signal transduction in pituitary tumoral cells: the role of cAMP\/PKA-induced filamin A phosphorylation","volume":"11","author":"Mangili","year":"2020","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.neo.2026.101322_bib0090","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.689","article-title":"Antipsychotic drugs elicit cytotoxicity in glioblastoma multiforme in a calcium-dependent, non-D(2) receptor-dependent, manner","volume":"9","author":"Weissenrieder","year":"2021","journal-title":"Pharmacol. Res. Perspect."},{"issue":"8098","key":"10.1016\/j.neo.2026.101322_bib0091","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s41586-025-09869-0","article-title":"Fasting boosts breast cancer therapy efficacy via glucocorticoid activation","volume":"649","author":"Padr\u00e3o","year":"2026","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0092","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13058-026-02230-x","article-title":"Targeting glucocorticoid receptor to enhance immunotherapy response in triple negative breast cancer","volume":"28","author":"Yang","year":"2026","journal-title":"Breast Cancer Res."},{"issue":"7749","key":"10.1016\/j.neo.2026.101322_bib0093","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41586-019-1019-4","article-title":"glucocorticoids promote breast cancer metastasis","volume":"567","author":"Obradovi\u0107","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0094","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1158\/1055-9965.EPI-20-0471","article-title":"The steroid metabolome and breast cancer risk in women with a family history of breast cancer: the novel role of adrenal androgens and glucocorticoids","volume":"30","author":"Houghton","year":"2021","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"2","key":"10.1016\/j.neo.2026.101322_bib0095","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.eprac.2022.11.009","article-title":"Evaluation of body composition in patients with and without adrenal tumors and without overt hypersecretory syndromes","volume":"29","author":"Araujo-Castro","year":"2023","journal-title":"Endocr. Pract."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0096","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12964-025-02129-8","article-title":"The Src family kinase inhibitor drug Dasatinib and glucocorticoids display synergistic activity against tongue squamous cell carcinoma and reduce MET kinase activity","volume":"23","author":"Hmedat","year":"2025","journal-title":"Cell Commun. Signal."},{"issue":"9","key":"10.1016\/j.neo.2026.101322_bib0097","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqab132","article-title":"Targeting glucocorticoid metabolism in prostate cancer","volume":"162","author":"Valle","year":"2021","journal-title":"Endocrinology"},{"key":"10.1016\/j.neo.2026.101322_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110172","article-title":"The role of thyroid hormone in the renal immune microenvironment","volume":"119","author":"Han","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"22","key":"10.1016\/j.neo.2026.101322_bib0099","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242216513","article-title":"Can Ashwagandha benefit the endocrine system?-A review","volume":"24","author":"Wici\u0144ski","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0100","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1186\/s12964-024-01917-y","article-title":"Breast cancer cells utilize T3 to trigger proliferation through cellular Ca(2+) modulation","volume":"22","author":"Tawfik","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.neo.2026.101322_bib0101","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2023.110745","article-title":"Triiodothyronine positively regulates endoplasmic reticulum-associated degradation (ERAD) and promotes androgenic signaling in androgen-dependent prostate cancer cells","volume":"109","author":"Erzurumlu","year":"2023","journal-title":"Cell Signal."},{"issue":"10","key":"10.1016\/j.neo.2026.101322_bib0102","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1002\/mc.23788","article-title":"Triiodothyronine (T3) suppresses hepatic tumorigenesis and development by inhibiting the phosphorylation of ERK","volume":"63","author":"Dong","year":"2024","journal-title":"Mol. Carcinog."},{"issue":"4","key":"10.1016\/j.neo.2026.101322_bib0103","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/HEP.0000000000000568","article-title":"Metabolic reprogramming in Nrf2-driven proliferation of normal rat hepatocytes","volume":"79","author":"Kowalik","year":"2024","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0104","doi-asserted-by":"crossref","first-page":"5505","DOI":"10.1038\/s41467-022-33215-x","article-title":"DNA methylation as a pharmacodynamic marker of glucocorticoid response and glioma survival","volume":"13","author":"Wiencke","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0105","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.stem.2025.12.009","article-title":"Pineal gland organoids illuminate human melatonin and circadian regulation","volume":"33","author":"Wang","year":"2026","journal-title":"Cell Stem Cell"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0106","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/ijms24010311","article-title":"Tumor microenvironment and metabolism: role of the mitochondrial melatonergic pathway in determining intercellular interactions in a new dynamic homeostasis","volume":"24","author":"Anderson","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.neo.2026.101322_bib0107","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12728","article-title":"Mitochondrial function is controlled by melatonin and its metabolites in vitro in human melanoma cells","volume":"70","author":"Bilska","year":"2021","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.neo.2026.101322_bib0108","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2026.111900","article-title":"Melatonin suppresses glycolysis and coordinately disrupts DNA repair via targeting the YAP1-NAMPT signaling in breast cancer","volume":"425","author":"Lai","year":"2026","journal-title":"Chem. Biol. Interact."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0109","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s11658-022-00375-z","article-title":"Melatonin and cancer suppression: insights into its effects on DNA methylation","volume":"27","author":"Davoodvandi","year":"2022","journal-title":"Cell Mol. Biol. Lett."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0110","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12951-025-03960-4","article-title":"In vivo dynamic monitoring of self-assembled melatonin nanodrug combined with photothermal effects to alleviate hypoxia to attenuate tumor aggressiveness","volume":"24","author":"Zeng","year":"2025","journal-title":"J. Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.neo.2026.101322_bib0111","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.449","article-title":"Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1","volume":"11","author":"Zhou","year":"2021","journal-title":"Clin. Transl. Med."},{"issue":"22","key":"10.1016\/j.neo.2026.101322_bib0112","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202408996","article-title":"Targeting melatonin to mitochondria mitigates castration-resistant prostate cancer by inducing pyroptosis","volume":"21","author":"Chen","year":"2025","journal-title":"Small"},{"issue":"5","key":"10.1016\/j.neo.2026.101322_bib0113","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.70072","article-title":"Melatonin induces PERK-ATF4 unfolded protein response and apoptosis in human choriocarcinoma cells","volume":"77","author":"Bienvenue-Pariseault","year":"2025","journal-title":"J. Pineal Res."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0114","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1038\/s41598-022-08778-w","article-title":"Effects of melatonin and metformin in preventing lysosome-induced autophagy and oxidative stress in rat models of carcinogenesis and the impact of high-fat diet","volume":"12","author":"Kurhaluk","year":"2022","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.neo.2026.101322_bib0115","doi-asserted-by":"crossref","first-page":"503","DOI":"10.2174\/1574892818666230419081414","article-title":"Co-delivery of Siape1 and Melatonin by (125)I-loaded PSMA-targeted nanoparticles for the treatment of prostate cancer","volume":"19","author":"Liu","year":"2024","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.neo.2026.101322_bib0116","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110900","article-title":"Co-treatment with melatonin and ortho-topolin riboside reduces cell viability by altering metabolic profiles in non-small cell lung cancer cells","volume":"391","author":"Lee","year":"2024","journal-title":"Chem. Biol. Interact."},{"issue":"19","key":"10.1016\/j.neo.2026.101322_bib0117","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.3390\/nu17193120","article-title":"Melatonin and vitamins: a promising combination to augment conventional anticancer therapies","volume":"17","author":"Talib","year":"2025","journal-title":"Nutrients"},{"issue":"6487","key":"10.1016\/j.neo.2026.101322_bib0118","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaw5473","article-title":"Metabolic reprogramming and cancer progression","volume":"368","author":"Faubert","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.neo.2026.101322_bib0119","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2021.107861","article-title":"Dietary nutrition for neurological disease therapy: current status and future directions","volume":"226","author":"Mao","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"8","key":"10.1016\/j.neo.2026.101322_bib0120","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","article-title":"Cancer neuroscience: state of the field, emerging directions","volume":"186","author":"Winkler","year":"2023","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0121","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1038\/s41467-024-48740-0","article-title":"Breast cancer cell-secreted miR-199b-5p hijacks neurometabolic coupling to promote brain metastasis","volume":"15","author":"Ruan","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.neo.2026.101322_bib0122","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.104802","article-title":"Lactate promotes neuronal differentiation of SH-SY5Y cells by lactate-responsive gene sets through NDRG3-dependent and -independent manners","volume":"299","author":"Xu","year":"2023","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0123","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1021\/acssensors.5c03203","article-title":"Comparative evaluation of hyperpolarized [(13)C]pyruvate and [(13)C]lactate for imaging neuronal and glioma metabolism","volume":"11","author":"Chen","year":"2026","journal-title":"ACS Sens."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0124","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12974-025-03551-y","article-title":"IL-1\u03b2(+) tumor-associated macrophages accelerate glioblastoma progression by amplifying the PGE2-EP4 signaling","volume":"22","author":"Liang","year":"2025","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.neo.2026.101322_bib0125","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1575472","article-title":"Hypercholesterolemia and the role of lipid metabolism gene CES1 in immune infiltration promote central nervous system relapse in acute myeloid leukemia","volume":"16","author":"Bao","year":"2025","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.neo.2026.101322_bib0126","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1093\/neuonc\/noac003","article-title":"IDH-mutated gliomas promote epileptogenesis through d-2-hydroxyglutarate-dependent mTOR hyperactivation","volume":"24","author":"Mortazavi","year":"2022","journal-title":"Neuro Oncol."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0127","article-title":"Pharmacoresistant seizures and IDH mutation in low-grade gliomas","volume":"3","author":"Correia","year":"2021","journal-title":"Neurooncol. Adv."},{"issue":"6","key":"10.1016\/j.neo.2026.101322_bib0128","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s13311-022-01238-3","article-title":"Targeting IDH-Mutant Glioma","volume":"19","author":"Miller","year":"2022","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.neo.2026.101322_bib0129","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1729589","article-title":"The role of a multidisciplinary clinic for management of patients with IDH mutant gliomas","volume":"15","author":"Aucoin","year":"2025","journal-title":"Front. Oncol."},{"issue":"Suppl 1","key":"10.1016\/j.neo.2026.101322_bib0130","first-page":"i38","article-title":"Symptom management in isocitrate dehydrogenase mutant glioma","volume":"12","author":"Walbert","year":"2025","journal-title":"Neurooncol. Pract."},{"issue":"12","key":"10.1016\/j.neo.2026.101322_bib0131","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168035","article-title":"Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors","volume":"133","author":"Drumm","year":"2023","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.neo.2026.101322_bib0132","article-title":"The IDH1 inhibitor ivosidenib improved seizures in a patient with drug-resistant epilepsy from IDH1 mutant oligodendroglioma","volume":"18","author":"Vo","year":"2022","journal-title":"Epilepsy Behav. Rep."},{"issue":"9","key":"10.1016\/j.neo.2026.101322_bib0133","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1080\/14728222.2022.2136570","article-title":"The adenosine A(2A) receptor is a therapeutic target in neurological, heart and oncogenic diseases","volume":"26","author":"Franco","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"issue":"3","key":"10.1016\/j.neo.2026.101322_bib0134","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/physrev.00049.2017","article-title":"Pharmacology of adenosine receptors: the state of the art","volume":"98","author":"Borea","year":"2018","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.neo.2026.101322_bib0135","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.3390\/biom13091387","article-title":"Pharmacology of adenosine receptors: recent advancements","volume":"13","author":"Vincenzi","year":"2023","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.neo.2026.101322_bib0136","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1124\/pharmrev.121.000445","article-title":"International union of basic and clinical pharmacology. CXII: adenosine receptors: a further update","volume":"74","author":"AP","year":"2022","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.neo.2026.101322_bib0137","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.62347\/ZYVY9443","article-title":"Adenosine receptor subtype modulators: insight into molecular mechanisms and their therapeutic application","volume":"17","author":"Solanki","year":"2025","journal-title":"Am. J. Transl. Res."},{"issue":"14","key":"10.1016\/j.neo.2026.101322_bib0138","doi-asserted-by":"crossref","first-page":"7685","DOI":"10.3390\/ijms22147685","article-title":"Adenosine and inflammation: here, there and everywhere","volume":"22","author":"Pasquini","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.neo.2026.101322_bib0139","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/bs.irn.2023.08.003","article-title":"Chemobrain: an accelerated aging process linking adenosine A(2A) receptor signaling in cancer survivors","volume":"170","author":"Oliveros","year":"2023","journal-title":"Int. Rev. Neurobiol."},{"issue":"12","key":"10.1016\/j.neo.2026.101322_bib0140","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1158\/1541-7786.MCR-19-0995","article-title":"Adenosine A2A receptor activation enhances blood-tumor barrier permeability in a rodent glioma model","volume":"19","author":"V\u00e9zina","year":"2021","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.neo.2026.101322_bib0141","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115184","article-title":"Drugs targeting adenosine signaling pathways: a current view","volume":"165","author":"Kutryb-Zaj\u0105c","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"11","key":"10.1016\/j.neo.2026.101322_bib0142","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1080\/17460441.2018.1534825","article-title":"Targeting adenosine A(2A) receptor antagonism for treatment of cancer","volume":"13","author":"Congreve","year":"2018","journal-title":"Expert Opin. Drug Discov."},{"issue":"16","key":"10.1016\/j.neo.2026.101322_bib0143","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.3390\/molecules29163847","article-title":"Novel quinazoline derivatives as highly effective A2A adenosine receptor antagonists","volume":"29","author":"Laversin","year":"2024","journal-title":"Molecules"},{"issue":"14","key":"10.1016\/j.neo.2026.101322_bib0144","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1111\/bph.15103","article-title":"Adenosine A(2A) receptor antagonists: from caffeine to selective non-xanthines","volume":"179","author":"Jacobson","year":"2022","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neo.2026.101322_bib0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2025.10.002","article-title":"METTL14 integrates tumor-derived SAM to drive parabrachial epigenetic rewiring in pancreatic cancer","volume":"114","author":"Yang","year":"2026","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.neo.2026.101322_bib0146","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41580-022-00572-w","article-title":"Metabolites as signaling molecules","volume":"24","author":"Baker","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.neo.2026.101322_bib0147","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101195","article-title":"Role of NAD(+) in regulating cellular and metabolic signaling pathways","volume":"49","author":"Amjad","year":"2021","journal-title":"Mol. Metab."},{"key":"10.1016\/j.neo.2026.101322_bib0148","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2022.111765","article-title":"SIRT6 serves as a polyhedron in glycolytic metabolism and ageing-related diseases","volume":"162","author":"Yuan","year":"2022","journal-title":"Exp. Gerontol."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0149","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s12935-025-03721-1","article-title":"Amino acid metabolism in glioblastoma pathogenesis, immune evasion, and treatment resistance","volume":"25","author":"Srivastava","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.neo.2026.101322_bib0150","article-title":"Tryptophan metabolism: mechanism-oriented therapy for neurological and psychiatric disorders","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.neo.2026.101322_bib0151","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.3390\/cells10082028","article-title":"Kynurenine monooxygenase expression and activity in human astrocytomas","volume":"10","author":"V\u00e1zquez Cervantes","year":"2021","journal-title":"Cells"},{"issue":"9","key":"10.1016\/j.neo.2026.101322_bib0152","first-page":"1404","article-title":"Saikosaponin D reverses epinephrine- and norepinephrine-induced gemcitabine resistance in intrahepatic cholangiocarcinoma by downregulating ADRB2\/glycolysis signaling","volume":"55","author":"He","year":"2023","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"5","key":"10.1016\/j.neo.2026.101322_bib0153","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167814","article-title":"Triiodothyronine promotes the proliferation and chemoresistance of cholangiocarcinoma cells via HIF-1\u03b1\/Glut1-stimulated glycolysis","volume":"1871","author":"Huang","year":"2025","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0154","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.tem.2017.10.010","article-title":"Therapeutic mechanisms of glucocorticoids","volume":"29","author":"Vandewalle","year":"2018","journal-title":"Trends Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.neo.2026.101322_bib0155","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/mc.23330","article-title":"ALKBH5-mediated m6A-demethylation of USP1 regulated T-cell acute lymphoblastic leukemia cell glucocorticoid resistance by Aurora B","volume":"60","author":"Gong","year":"2021","journal-title":"Mol. Carcinog."},{"issue":"18","key":"10.1016\/j.neo.2026.101322_bib0156","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1038\/s41388-025-03305-3","article-title":"SUMOylation inhibition potentiates the glucocorticoid receptor to program growth arrest of acute lymphoblastic leukemia cells","volume":"44","author":"Valima","year":"2025","journal-title":"Oncogene"},{"issue":"11","key":"10.1016\/j.neo.2026.101322_bib0157","doi-asserted-by":"crossref","first-page":"5889","DOI":"10.3390\/ijms22115889","article-title":"Dual mechanisms of metabolism and gene expression of the CCRF-CEM leukemia cells under glucocorticoid treatment","volume":"22","author":"Lambrou","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0158","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1186\/s12885-021-08804-6","article-title":"Effect of EPA on Hsp90 and gr\u03b1 protein expression in multiple myeloma drug-resistant cells","volume":"21","author":"Wu","year":"2021","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0159","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41392-025-02334-4","article-title":"Targeting metabolic-epigenetic-immune axis in cancer: molecular mechanisms and therapeutic implications","volume":"11","author":"Wang","year":"2026","journal-title":"Sig. Transduct. Target Ther."},{"issue":"3","key":"10.1016\/j.neo.2026.101322_bib0160","doi-asserted-by":"crossref","DOI":"10.1177\/00368504251381592","article-title":"miR-199a-5p\/GPR89A axis modulates sorafenib resistance in hepatocellular carcinoma through glutamate metabolic reprogramming","volume":"108","author":"Li","year":"2025","journal-title":"Sci. Prog."},{"issue":"1","key":"10.1016\/j.neo.2026.101322_bib0161","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18044","article-title":"Mechanism of ferroptosis in breast cancer and research progress of natural compounds regulating ferroptosis","volume":"28","author":"Ge","year":"2024","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.neo.2026.101322_bib0162","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41419-023-05770-8","article-title":"Melatonin inhibits bladder tumorigenesis by suppressing PPAR\u03b3\/ENO1-mediated glycolysis","volume":"14","author":"Shen","year":"2023","journal-title":"Cell Death Dis."},{"issue":"44","key":"10.1016\/j.neo.2026.101322_bib0163","doi-asserted-by":"crossref","first-page":"6273","DOI":"10.1038\/s41388-021-02015-w","article-title":"Melatonin potentiates the cytotoxic effect of Neratinib in HER2(+) breast cancer through promoting endocytosis and lysosomal degradation of HER2","volume":"40","author":"Liu","year":"2021","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2026.101322_bib0164","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101024","article-title":"The advancements and prospective developments in anti-tumor targeted therapy","volume":"56","author":"Leng","year":"2024","journal-title":"Neoplasia"},{"issue":"47","key":"10.1016\/j.neo.2026.101322_bib0165","doi-asserted-by":"crossref","first-page":"18492","DOI":"10.1523\/JNEUROSCI.1828-13.2013","article-title":"Antagonistic interaction between adenosine A2A receptors and Na+\/K+-ATPase-\u03b12 controlling glutamate uptake in astrocytes","volume":"33","author":"Matos","year":"2013","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.neo.2026.101322_bib0166","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12975-019-00708-9","article-title":"NDRG2 protects the brain from excitotoxicity by facilitating interstitial glutamate uptake","volume":"11","author":"Yin","year":"2020","journal-title":"Transl. Stroke Res."}],"updated-by":[{"DOI":"10.1016\/j.neo.2026.101355","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558626000527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T04:22:20Z","timestamp":1788668540000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558626000527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":166,"alternative-id":["S1476558626000527"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2026.101322","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A malignant symbiosis: The neuro-metabolic symphony rewires the tumor microenvironment","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2026.101322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101322"}}